Dabur India Ltd News

Dabur accuses FSSAI of favouring rivals over '100%' product claims

Dabur has accused FSSAI of favouring other manufacturers over its restrictions on "100 per cent" claims on food products

Delhi HC stays FSSAI order restricting Dabur's use of '100%' product claims

The court said Dabur should have been heard before the directive was issued; the company warned that compliance could affect products worth more than ₹150 crore

Dabur shares off day's low, turn positive after Delhi HC stays FSSAI order

Gaurang Shah of Geojit Financial Services said that Dabur has been in the market for a long time, has a good amount of goodwill for its products and an unmatched product portfolio.

Dabur challenges FSSAI order banning '100%' claims in Delhi High Court

Dabur has moved the Delhi High Court against an FSSAI order directing it to stop selling food products carrying "100%" claims. The matter is likely to be heard on Friday

FSSAI's crackdown: Why food brands and liquor firms are under scanner

From misleading labels and '100%' purity claims to liquor, nutraceuticals, packaged water and quick commerce, here's a look at FSSAI's recent enforcement actions

USFDA issues warning letter to Dabur over CGMP lapses at Silvassa plant

The US Food and Drug Administration (USFDA) has issued a warning letter to home-grown FMCG major Dabur India citing significant violations of current good manufacturing practices (CGMP) at its pharmaceutical manufacturing facility in Silvassa. The warning letter follows an inspection conducted by the US health regulator at the company's facility in Silvassa, Dadra and Nagar Haveli and Daman and Diu, from January to December 16, 2026. USDFA, in its letter dated July 24, 2027, to Dabur India CEO Mohit Malhotra, has pointed out data integrity lapses, inadequate quality oversight and deficient manufacturing controls. According to the USFDA, the facility's methods, controls and manufacturing practices did not conform to CGMP requirements, resulting in the products being considered "adulterated" under the US Federal Food, Drug and Cosmetic Act. Among the most serious findings, the USFDA said its investigator discovered that an equipment usage logbook provided by the company for a ...

Dabur seeks legal advice on future course after FSSAI prohibitory order

The FMCG major said it is engaging with the food regulator after it barred the sale of products carrying '100 per cent' claims and sought an action taken report.

Dabur India share price dips 3%, nears 52-week low; here's why

According to reports, the food regulator FSSAI has prohibited Dabur India from selling many products such as honey, cow ghee, and edible oils using '100%' claims; BSE seeks clarification.

FSSAI bars Dabur from selling food products with misleading '100%' claims

Food regulator FSSAI has prohibited Dabur India from selling many products such as honey, cow ghee, and edible oils using '100 per cent' claims, saying that such labelling is against the law. In a social media post on Monday, Food Safety and Standards Authority of India (FSSAI) informed that it has issued a prohibition order to Dabur India Ltd over the sales of food products carrying misleading '100 per cent' claims, including honey, apple cider vinegar, virgin coconut oil, sesame oil, cow ghee, coconut water, coconut milk and other such items. Giving details about the violations, the FSSAI said that "food products being sold on the company's website were found carrying misleading '100%' claims such as '100% Natural', '100% Pure', '100% Purity Guaranteed', '100% Organic' and '100% Tender Coconut Water'." The regulator asserted that the use of the 100 per cent claims is in contravention of the FSS (Advertising & Claims) Regulations, 2018, as they are ambiguous, unverifiable and ...

Stocks to watch: LIC, Bharti Airtel, BSE, Dabur, IREDA & others

Bharti Airtel, BSE, Deepak Nitrite, Godrej Properties, Emami, Kalyan Jewellers, MCX, Marico, Nykaa, ONGC, PNB Housing and UBL among key companies slated to post their earnings today.

Dabur India share price falls 4% after Q1; brokerage trims target

Dabur India reported a 15 percent year-on-year increase in its consolidated net profit to ₹591 crore

24,200 key for Nifty, says HDFC Securities; recommends 2 stocks to buy

The broader trend remains choppy, with Nifty trading below its 20-day and 100-day EMAs and placed above 50 DEMA.

Dabur's double-digit Q1FY27 growth must sustain to drive stock rerating

Strong Q1FY27 revenue growth, improving rural demand and healthy international business support Dabur's outlook, but sustained revenue momentum remains crucial for a stock rerating

Dabur expects strong Q1 profit growth as price hikes cushion inflation

The FMCG major said higher prices helped offset inflationary pressures, while rural demand and international markets continued to drive growth

FMCG stocks in demand: Nifty FMCG index up 1.7%; Nestle India, GCPL lead

Aamar Deo Singh of Angel One said that it is still early to turn decisively bullish on FMCG and that "investors should wait for the monsoon outcome and further confirmation of a sustained recovery."

Stocks to Watch today: Vedanta, Cipla, Dabur, Vi, Oil India, CDSL and more

Stocks to watch today: Vedanta, Cipla, Dabur, Vi, Oil India, CDSL, Ratnaveer Precision, NLC India, Sagility among others will in focus today.

US drug regulator issues import alert for drugs made at a Dabur India plant

The action was taken after the FDA inspected the factory and flagged data integrity and maintenance lapses

FMCG shares in focus; HUL, Dabur, Nestle, Marico gain up to 3%; here's why

Despite global uncertainties, subpar monsoon outlook and volatile commodity prices, FMCG firms have given resilient outlook for FY27 with H2FY27 expected to be better versus H1FY27, say analysts.

Nifty FMCG index sheds 2%; Dabur slips 4%; ITC, Britannia hit 52-week lows

In the past one month, the FMCG index has underperformed the market, by falling 5 per cent, as against 2.3 per cent decline in Nifty 50.

Dabur India stock surges 4% after Q4 results; should investors buy now?

Dabur India shares climbed nearly 4 per cent on Friday after Q4FY26 results. Most rokerages retained ratings & targets and highlighted improving India business growth despite execution concerns